AXGN
AxoGen Surpasses Expectations in Q2 2026: Strong Revenue Growth and Expanded Market Reach
July 29, 2026 - AxoGen, a leading company in the field of nerve repair and regeneration, has reported a strong second quarter performance for 2026. The company's President and Chief Executive Officer, Michael Dale, highlighted the key highlights from the quarter during a recent conference call. AxoGen'